6670 related articles for article (PubMed ID: 2828246)
1. Evidence for alpha-melanocyte-stimulating hormone (alpha-MSH) receptors on human malignant melanoma cells.
Ghanem GE; Comunale G; Libert A; Vercammen-Grandjean A; Lejeune FJ
Int J Cancer; 1988 Feb; 41(2):248-55. PubMed ID: 2828246
[TBL] [Abstract][Full Text] [Related]
2. Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion.
Storm FK; Sparks FC; Morton DL
Surg Gynecol Obstet; 1979 Jul; 149(1):17-21. PubMed ID: 451822
[TBL] [Abstract][Full Text] [Related]
3. Heparanases and tumor metastasis.
Nakajima M; Irimura T; Nicolson GL
J Cell Biochem; 1988 Feb; 36(2):157-67. PubMed ID: 3281960
[TBL] [Abstract][Full Text] [Related]
4. [Metastatic melanoma B16 of the C57Bl/6J mouse. Biological findings].
Voulot C; Aubert C; Rougé F; Douss T; Santini R
C R Seances Soc Biol Fil; 1985; 179(4):445-51. PubMed ID: 2938673
[TBL] [Abstract][Full Text] [Related]
5. Effects of hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan on pulmonary function assessments.
Sleijfer S; van Ginkel RJ; van der Mark TW; Hoekstra HJ; Zwaveling JH; Schraffordt Koops H; Mulder NH
J Immunother; 1997 May; 20(3):202-7. PubMed ID: 9181458
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in skin cancer.
D'errico M; Calcagnile A; Dogliotti E
Ann Ist Super Sanita; 1996; 32(1):53-63. PubMed ID: 8804185
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.
Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
J Cancer Res Clin Oncol; 1994; 120(11):631-5. PubMed ID: 7962038
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the uptake of nucleosides in cultured Harding-Passey melanoma cells by diflubenzuron.
Mayer RT; Netter KJ; Leising HB; Schachtschabel DO
Toxicology; 1984 Feb; 30(1):1-6. PubMed ID: 6422584
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell attachment and degradation of basement membranes.
Liotta LA; Rao NC; Terranova VP; Barsky S; Thorgeirsson U
Symp Fundam Cancer Res; 1983; 36():169-76. PubMed ID: 6089291
[No Abstract] [Full Text] [Related]
10. A comparison of lung metastases and natural killer cell activity in daily fractions and weekly fractions of radiation therapy on murine B16a melanoma.
Shen RN; Hornback NB; Shidnia H; Lu L; Montebello JF; Brahmi Z
Radiat Res; 1988 May; 114(2):354-60. PubMed ID: 3375430
[TBL] [Abstract][Full Text] [Related]
11. Labial melanotic macule: a clinical, histopathologic, and ultrastructural study.
Ho KK; Dervan P; O'Loughlin S; Powell FC
J Am Acad Dermatol; 1993 Jan; 28(1):33-9. PubMed ID: 8425968
[TBL] [Abstract][Full Text] [Related]
12. An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models.
Rosenblum MG; Cheung L; Mujoo K; Murray JL
Cancer Immunol Immunother; 1995 May; 40(5):322-8. PubMed ID: 7600565
[TBL] [Abstract][Full Text] [Related]
13. Agents with potential specificity against melanotic melanoma.
Lin AJ; Kelley JA; Breitman TR; Driscoll JS
J Med Chem; 1982 May; 25(5):501-5. PubMed ID: 7086835
[TBL] [Abstract][Full Text] [Related]
14. Initial clinical studies with copovithane.
Hortobagyi GN; Hersh EM; Papadopoulos NE; Frye D; Rios A; Reuben JM; Plager C; Rosenblum M; Quesada J
J Biol Response Mod; 1986 Aug; 5(4):319-29. PubMed ID: 2942646
[TBL] [Abstract][Full Text] [Related]
15. Nisamycin, a new manumycin group antibiotic from Streptomyces sp. K106. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties.
Hayashi K; Nakagawa M; Nakayama M
J Antibiot (Tokyo); 1994 Oct; 47(10):1104-9. PubMed ID: 7961159
[TBL] [Abstract][Full Text] [Related]
16. The use of biomarkers to study pathogenesis and mechanisms of cancer: oesophagus and skin cancer as models.
Montesano R; Hainaut P; Hall J
IARC Sci Publ; 1997; (142):291-301. PubMed ID: 9354928
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine modulation of tumor metastases. I. Effect of adrenalectomy on B16 melanoma metastases.
Kitson RP; Brunson KW; Miller CA; Goldfarb RH
In Vivo; 1994; 8(5):803-6. PubMed ID: 7727728
[TBL] [Abstract][Full Text] [Related]
18. Interactions of daunomycin and melanotropin-daunomycin with DNA.
Weisehahn G; Varga JM; Hearst JE
Nature; 1981 Jul; 292(5822):467-9. PubMed ID: 7254342
[No Abstract] [Full Text] [Related]
19. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.
Pritchard DJ; Ritts RE; Taylor WF; Miller GC
Cancer; 1978 Jun; 41(6):2165-73. PubMed ID: 306870
[TBL] [Abstract][Full Text] [Related]
20. PET in oncology: will it replace the other modalities?
Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
